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Introduction
Cefazolin is a broad-spectrum first-generation cephalosporin antibiotic. It is used for the treatment of a number of both Gram-positive (i.e., Staphylococcus epidermidis, Streptococcus 
pyogenes, Staphylococcus aureus, Streptococcus agalactiae, 
Streptococcus pneumonia, and other strains of streptococci) 
and Gram-negative (i.e., Escherichia coli, Proteus mirabilis, 
etc.) bacterial infections [1,2]. Cefazolin inhibits the growth of 
bacteria by restricting the bacterial cell wall synthesis [3]. It is used for the treatment of diseases like Urinary Tract Infections (UTIs), respiratory tract infections, pneumonia, cellulitis, 
endocarditis, joint infection, blood infections, genital infections, biliary tract infections, and also prevent the streptococcal 
disease in the time of delivery and before surgery, etc. [1,2]. 
Some amount of cefazolin enters in the breast milk during the 
pregnancy and breastfeeding, so safety needs to follow in that 
 
period. Many side effects associated with the cefazolin 
medication are diarrhoea, vomiting, stomach pain, rash, blood 
dyscrasias, allergic reaction, hypoprothrombinemia, etc. [2,3]. The sodium salt form of cefazolin (cefazolin sodium) available 
in various dosage form, i.e., injectable, powder for injection, 
eye drop, etc. [4]. It is a white crystalline powder, insoluble in 
chloroform, acetone, dichloromethane, and ethyl acetate; slightly 
soluble in ethanol and methanol; and freely soluble in water and 
isopropanol; it has no fixed melting point but decompose at the temperature of ~193 °C [5].The physicochemical properties of a pharmaceutical compound is very important for the dissolution, absorption, and 
bioavailability in the body [6]. All over the world pharmaceutical 
scientists working for the improvement of stability and bioavailability of pharmaceutical and nutraceutical compounds. 
Abstract
Cefazolin is a broad-spectrum first-generation cephalosporin antibiotic, used for the treatment of a number of bacterial infections. The aim 
of this research work was to evaluate the influence of the Trivedi Effect®-Consciousness Energy Healing Treatment on the physicochemical, and 
thermal properties of cefazolin sodium powder using modern analytical techniques. The test sample cefazolin sodium was divided into two parts. 
One part of the test sample was considered as a control sample (no Biofield Energy Treatment was provided), whereas the other part was treated 
with the Consciousness Energy Healing Treatment remotely by a renowned Biofield Energy Healer, Gopal Nayak and termed as a treated sample. 
The particle size values in the treated sample were significantly decreased by 3.95%(d10), 2.63%(d50), 13.02%(d90), and 21.7% {D (4,3)}; hence, the 
specific surface area was increased by 5% compared to the control sample. The decomposition temperature of the treated cefazolin was increased 
by 4.84 compared to the control sample. Similarly, the latent heat of evaporation of two peaks and decomposition was significantly increased by 
56.81%, 225.38%, and 261.84% in the treated sample compared with the control sample. The total weight loss was decreased by 2.7%; however, 
the residual amount was significantly increased by 28.59% in the treated cefazolin compared with the control sample. A new form of cefazolin 
sodium might have generated after Trivedi Effect®-Consciousness Energy Healing Treatment which may offer better solubility, dissolution rate, 
bioavailability, and thermal stability compared to the control sample. The treated cefazolin sodium would be more efficacious pharmaceutical 
formulations against respiratory tract infections, cellulitis, urinary tract infections, joint infection, biliary tract infections, pneumonia, endocarditis, 
genital infections, blood infections, etc.
Keywords: Cefazolin sodium; The Trivedi Effect®; Consciousness energy healing treatment; Complementary and alternative medicine; Particle size; 
Surface area; DSC
Abbreviations: UTI: Urinary Tract Infections; CAM: Complementary and Alternative Medicine; PSA: Particle Size Analysis; PXRD: Powder X-Ray 
Diffraction; DSC: Differential Scanning Calorimetry; TGA: Thermo Gravimetric Analysis; DTG: Differential Thermo Gravimetric Analysis 
How to cite this article: Gopal Nayak, Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Snehasis Jana. Effect of the Consciousness Energy 
Healing Treatment on the Characteristic Properties of Cefazolin Sodium. Adv Biotech & Micro. 2019; 13(1): 555852. DOI: 10.19080/AIBM.2019.13.555852.002
Advances in Biotechnology & Microbiology
Similarly, The Trivedi Effect®-Consciousness Energy Healing 
Treatment is one of the approaches which has the significant impact on the crystallite size, particle size, particle surface area, thermal behavior, and bioavailability of pharmaceutical/ 
nutraceutical compounds [7-9]. The Trivedi Effect® is a natural 
and only scientifically proven phenomenon in which a person can 
harness this inherently intelligent energy from the “Universe” 
and transmit it anywhere on the planet through the possible 
mediation of neutrinos [10]. A unique, infinite, and para-
dimensional electromagnetic field exists around every living 
organism, which originates from the continuous movements 
of the charged particles, ions, cells, blood/lymph flow, brain 
functions, heart, etc. in the body known as Biofield. The Biofield 
Energy Healer has a unique capability to harness energy from 
the “Universe” and can transmit anywhere in the world. This 
Biofield Energy Therapy has been reported with significantly 
beneficial outcomes against various disease conditions [11].
The National Institutes of Health/National Center for Com-
plementary and Alternative Medicine (NIH/NCCAM) recom-
mend and included the Energy therapy under Complementary 
and Alternative Medicine (CAM) category along with Yoga, ho-meopathy, Ayurveda medicine, Chinese herb and medicine, etc. that has been accepted by most of the U.S.A. population [12, 13]. 
The Trivedi Effect®-Consciousness Energy Healing Treatment 
has also shown significant impacts on the physicochemical and 
behavior of metals, organic compounds, ceramics [14-19], crops, 
cancer cell line, microbes [20-24]. Therefore, this experiment 
was designed to evaluate the impact of the Trivedi Effect®-Con-
sciousness Energy Healing Treatment on the physicochemical, 
thermal, and behavioral properties of cefazolin sodium powder 
sample using Particle Size Analysis (PSA), Powder X-Ray Diffrac-
tion (PXRD), Differential Scanning Calorimetry (DSC), and Ther-
mo Gravimetric Analysis (TGA)/ Differential Thermo Gravimet-
ric analysis (DTG).
Materials and Methods
Chemicals and reagentsCefazolin sodium (C14H13N8NaO4S3) powder was purchased from Tokyo Chemical Industry Co, Ltd, Japan and the additional 
chemicals were of analytical grade purchased in India. 
Consciousness energy healing treatment strategies
The cefazolin sodium test sample was divided into two parts. 
One part of the test sample was received the Trivedi Effect®-
Consciousness Energy Healing Treatment remotely under the 
standard laboratory conditions for 3 minutes by the renowned 
Biofield Energy Healer, Gopal Nayak, India, and known as the 
Biofield Energy Treated sample. However, the second part of 
cefazolin powder sample was considered as a control sample, 
which did not receive the Biofield Energy Treatment. Later, the 
control sample was treated with a “sham” healer; however, the 
sham healer did not have any knowledge about the Biofield 
Energy Treatment. After the treatment, the Biofield Energy 
Treated and control cefazolin sodium powder samples were kept 
in sealed condition and characterized using PSA, PXRD, DSC, and 
TGA/DTG analytical techniques.
Characterization
Particle size analysis (PSA)
The particle size analysis of cefazolin sodium powder 
samples was conducted on Malvern Rasterizer 2000, from the 
UK with a detection range between 0.01 µm to 3000 µm using 
wet method [7, 8]. The percent change in particle size (d) for 
cefazolin sodium powder sample at below 10% level (d10), 50% level (d50), 90% level (d90), and D (4,3) was calculated using the 
following equation 1    [ ]%    100Treated Control
Control
d dchange in particle size
d
−
= ×         (1)Where dControl and dTreated are the particle size (μm) for at 
below 10% level (d10), 50% level (d50), and 
90% level (d90) of the control and Biofield Energy Treated samples, respectively.
The % change in surface area (S) was calculated using the 
following equation 2  [ ]%    100Treated Control
Control
S Schange in surface area
S
−
= ×             (2)Where SControl and STreated are the surface area of the control 
and Biofield Energy Treated cefazolin sodium powder sample, respectively.
Powder X-ray diffraction (PXRD) analysis
The PXRD analysis of cefazolin sodium powder samples were 
performed with the help of Rigaku MiniFlex-II Desktop X-ray 
diffractometer (Japan) [25, 26]. The average size of individual 
crystallites are generally calculated using the Scherrer’s formula (3):
                                 G = kλ/βcosθ        (3)
Where k is the equipment constant (0.94), G is the crystallite 
size in nm, λ is the radiation wavelength (0.154056 nm for Kα1 
emission), β is the Full-Width at Half Maximum (FWHM), and θ 
is the Bragg angle [27].
Differential scanning calorimetry (DSC) 
The DSC analysis of cefazolin sodium powder samples was 
performed with the help of DSC Q200, TA instruments. The 
sample of ~1-2 mg was loaded to the aluminium sample pan at 
a heating rate of 10 ºC/min from 30°C to 350°C [7, 8]. The % 
change in melting point (T) was calculated using the following 
equation 4:
[ ]%    100Treated Control
Control
T Tchange in melting point
T
−
= ×    (4)Where TControl and TTreated are the melting point of the control 
and Biofield Energy Treated samples, respectively.
The % change in the latent heat of fusion (ΔH) was calculated 
using the following equation 5:
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  [ ]%      100Treated Control
Control
H Hchange in latent heat of fusion
H
∆ −∆
= ×
∆
         (5)
Where ΔHControl and ΔHTreated are the latent heat of fusion 
of the control and Biofield Energy Treated cefazolin sodium 
powder sample, respectively.
Thermal gravimetric analysis (TGA) / differential 
thermo gravimetric analysis (DTG)
TGA/DTG thermograms of cefazolin sodium powder samples 
were carried out with the help of TGA Q50 TA instruments. 
Sample of ~4-7 mg was loaded to the platinum crucible at a 
heating rate of 10oC/min from 25°C to 1000°C with the recent 
literature [7, 8]. The % change in weight loss (W) was calculated 
using the following equation 6:
[ ]%    100Treated Control
Control
W Wchange in weight loss
W
−
= ×              (6)Where WControl and WTreated are the weight loss of the control 
and Biofield Energy Treated cefazolin sodium, respectively.
The % change in maximum thermal degradation temperature 
(Tmax) (M) was calculated using the following equation 7:
( ) [ ]%   100Treated Controlmax
Control
M Mchange in T M
M
−
= ×                       (7)Where MControl and MTreated are the Tmax values of the control 
and Biofield Energy Treated cefazolin sodium, respectively.
Results and Discussion
Particle size analysis (PSA)
Table 1: Particle size distribution of the control and Biofield Energy 
Treated cefazolin sodium
Parameter d10 (µm) d50 (µm) d90 (µm) D (4,3) 
(µm)
SSA 
(m2/g)Control 4.88 37.38 193.74 82.84 0.5
Biofield Treated 4.69 36.4 168.52 64.86 0.525Percent 
Change* (%)
-3.95 -2.63 -13.02 -21.7 5
d10, d50, and d90: particle diameter corresponding to 10%, 50%, and 
90% of the cumulative distribution, D(4,3): the average mass-volume 
diameter, and SSA: the specific surface area.
*denotes the percentage change in the Particle size distribution of the 
Biofield Energy Treated sample with respect to the control sample.
The PSD data of both the control and Biofield Energy Treated cefazolin are presented in Table 1. The particle size values of the control sample at d10, d50, d90, and D (4,3) were 4.88 µm, 
37.38 µm, 193.74 µm, and 82.84 µm, respectively. Likewise, the 
particle sizes of the Biofield Energy Treated sample at d10, d50, d90, and D (4,3) were 4.69 µm, 36.4 µm, 168.52 µm, and 64.86 
µm, respectively. The particle size values in the treated sample 
were significantly decreased at d10, d50, d90, and D (4,3) by 3.95%, 
2.63%, 13.02%, and 21.7% compared to the control sample. 
The Specific Surface Area (SSA) of the Biofield Energy Treated 
sample (0.525 m2/g) was increased by 5% compared to the control sample (0.5 m2/g). It can be assumed that the Trivedi 
Effect® might have fractured the larger particle into smaller one, 
hence increased surface area. Due to the reduced particle size and increase surface area, the solubility, dissolution rate, and 
bioavailability would be higher the physiological system [6,28, 
29]. Thus, the Consciousness Energy Healing Treated cefazolin 
sodium might offer better solubility, dissolution rate, and 
bioavailability compared with the untreated sample.
Powder X-ray diffraction (PXRD) analysis 
Both the control and the Biofield Energy Treated cefazolin 
sodium samples did not show any clear, sharp, and intense peaks 
in the PXRD diffractograms (Figure 1). Therefore, it was difficult 
to compare PXRD of the Biofield Energy Treated cefazolin 
sodium with the control sample. It was concluded that both the 
samples were amorphous.
Figure 1: PXRD diffractograms of the control and Biofield 
Energy Treated cefazolin sodium.
Figure 2: DSC thermograms of the control and biofield energy 
treated cefazolin sodium.
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Differential scanning calorimetry (DSC) analysis 
The DSC thermograms of the control and Biofield Energy 
Treated cefazolin sodium showed two endothermic and one 
exothermic peak (Figure 2). The evaporation temperatures of 
the Biofield Energy Treated cefazolin sodium was slightly altered 
by -3.82% and 1.51%, but the decomposition temperature was 
increased by 4.85% compared with the control sample (Table 2).
Table 2: DSC data for both control and Biofield Energy Treated samples of cefazolin sodium.
Sample  Evaporation Temp (°C)
Decomposition 
Temp (°C)
∆H (J/g)
Evaporation DecompositionControl Sample 91.84 106.68 178.17 6.39 27.78 43.5
Biofield Energy Treated 88.33 108.29 186.82 10.02 90.39 157.4
% Change* -3.82 1.51 4.85 56.81 225.38 261.84
ΔH: Latent heat of evaporation/decomposition.
*denotes the percentage change of the Biofield Energy Treated cefazolin sodium with respect to the control sample.
The latent heat of evaporation (∆Hevaporation) of the Biofield 
Energy Treated cefazolin sodium was significantly increased by 
56.81% and 225.38% compared with the control sample (Table 
2). Similarly, the latent heat of decomposition (∆Hdecomposition) of 
the Biofield Energy Treated sample was significantly increased 
by 261.84% compared with the control sample (Table 2). The disrupted the molecular chains and crystal structure of cefazolin 
[30], might be the root cause of altered thermal stability of the 
Biofield Energy Treated sample compared to the control sample.
Thermal gravimetric analysis (TGA) / differential 
thermo gravimetric analysis (DTG)
The TGA thermograms of the control and Biofield Energy 
Treated cefazolin sodium samples showed three steps of thermal 
degradation (Figure 3). The total weight loss in the Biofield 
Energy Treated sample was decreased by 2.7% compared with 
the control sample (Table 3). However, the residue amount was 
significantly increased by 28.59% in the Biofield Energy Treated cefazolin sample compared to the control sample (Table 3).
Figure 3: TGA thermograms of the control and biofield energy 
treated cefazolin sodium.
Table 3: TGA/DTG data of the control and Biofield Energy Treated 
samples of cefazolin sodium.
Sample
TGA DTG
Total 
Weight 
Loss (%)
Residue %
Peak 1 
Tmax (°C)
Peak 2
Tmax (°C)T
max
 (°C) Peak 2T
max
 (°C)Control 91.36 8.64 185.89 851.61 Biofield 
Energy Treated 88.89 11.11 183.04 808.74
% Change* -2.7 28.59 -1.53 -5.03
*denotes the percentage change of the Biofield Energy Treated 
sample with respect to the control sample
Tmax = the temperature at which maximum weight loss takes place in 
TG or peak temperature in DTG.
Figure 4: DTG thermograms of the control and biofield energy 
treated cefazolin sodium.
The control and Biofield Energy Treated cefazolin sodium 
exhibited two peaks in the DTG thermograms (Figure 4). The 
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maximum thermal degradation temperature (T
max
) of the 1st 
and 2nd peaks of Biofield Energy Treated sample were slightly 
altered by -1.53% and -5.03% compared to the control sample 
(Table 3). Overall, thermal analysis by DSC and TGA/DTG of the 
samples revealed that the thermal stability of the Biofield Energy 
Treated cefazolin sodium was significantly improved compared 
with the control sample.
Conclusion
The Trivedi Effect®-Consciousness Energy Healing Treatment 
has significant effects on the physicochemical and thermal properties of cefazolin sodium. The particle size values in the 
Biofield Energy Treated sample were significantly decreased by 
3.95%(d10), 2.63%(d50), 13.02%(d90), and 21.7% {D (4,3)}; hence, 
the specific surface area was increased by 5% compared to the 
control sample. The decomposition temperature of the Biofield 
Energy Treated cefazolin was increased by 4.84 compared to 
the control sample. Similarly, the ∆Hevaporation of two peaks and 
∆Hdecomposition was significantly increased by 56.81%, 225.38%, 
and 261.84% in the Biofield Energy Treated sample compared 
with the control sample. The total weight loss was decreased by 
2.7%; however, the residual amount was significantly increased 
by 28.59% in the Biofield Energy Treated cefazolin compared 
with the control sample. A new form of cefazolin sodium might 
have generated after Trivedi Effect®-Consciousness Energy 
Healing Treatment which may offer better solubility, dissolution rate, bioavailability, and thermal stability compared to the control sample.
The Biofield Energy Treated cefazolin sodium would 
be more efficacious pharmaceutical formulations against respiratory tract infections, cellulitis, urinary tract infections, joint infection, biliary tract infections, pneumonia, endocarditis, 
genital infections, blood infections, and also prevent group B 
streptococcal disease at the time of delivery and before surgery, etc.
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